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Abstract 1 
Collagen is a trimer of three left-handed alpha-chains representing repeats of the 2 
motif Gly-X-Y, whereas (hydroxy)proline and (hydroxy)lysine residues are often 3 
found at positions X and Y. Selected hydroxylysine are further modified by the 4 
addition of galactose and glucose-galactose units. Collagen glycosylation takes place 5 
in the endoplasmic reticulum before triple helix formation and is mediated by β(1-6 
O)galactosyl- and α(1-2)glucosyltransferase enzymes. We have identified two 7 
collagen galactosyltransferases using affinity chromatography and tandem-MS 8 
protein sequencing. The two collagen β(1-O)galactosyltransferases corresponded to 9 
the GLT25D1 and GLT25D2 proteins. Recombinant GLT25D1 and GLT25D2 enzymes 10 
showed a strong galactosyltransferase activity towards various types of collagen and 11 
towards the serum mannose-binding lectin MBL, which contains a collagen domain. 12 
Amino acid analysis of the products of GLT25D1 and GLT25D2 reactions confirmed 13 
the transfer of galactose to hydroxylysine residues. The GLT25D1 gene is 14 
constitutively expressed in human tissues, whereas the GLT25D2 gene is only 15 
expressed at low levels in the nervous system. The GLT25D1 and GLT25D2 enzymes 16 
are similar to CEECAM1, to which we could not attribute any collagen 17 
galactosyltransferase activity. The GLT25D1 and GLT25D2 genes now allow 18 
addressing the biological significance of collagen glycosylation and the importance of 19 
this post-translational modification in the etiology of connective tissue disorders. 20 
21 
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Introduction 1 
Collagens are the most abundant proteins in the human body. To date, 29 types of 2 
collagen have been described, which are encoded by at least 44 genes (21, 37, 45). 3 
Collagens are characterized by domains representing repeats of the triplet Gly-X-Y, 4 
where proline and lysine are often found at the positions X and Y. The Gly-X-Y 5 
repeats are not confined to collagens, but are also found in several proteins, such as 6 
the hormone adiponectin (29), the mannose-binding lectin (MBL) (11), the C1q 7 
complement protein (35), the COLQ subunit of the acetylcholine esterase complex (4) 8 
and the surfactant proteins SP-A and SP-D (11).  9 
After synthesis in the endoplasmic reticulum (ER), three procollagen subunits 10 
associate to build a right-handed triple helix. However, before the formation of the 11 
triple helix structure, the nascent procollagen polypeptides undergo several post-12 
translational modifications. These modifications comprise the hydroxylation of 13 
selected proline (20) and lysine (33) residues, which are catalyzed by three prolyl-4-14 
hydroxylases (17), one prolyl-3-hydroxylase (46) and three lysyl hydroxylases (43). 15 
Hydroxylysine can be further modified by the addition of the monosaccharide 16 
Gal(β1-O) or the disaccharide Glc(α1-2)Gal(β1-O) (39). 17 
Whereas the glycosylation of collagen has been first described by Grassmann and 18 
Schleich in 1935 (9) and the structure of the glycan determined by Spiro in 1967 as 19 
being Glc(α1-2)Gal(β1-O)Hyl (40), the molecular nature of the collagen 20 
glycosyltransferase enzymes has remained elusive up to now. Collagen 21 
galactosyltransferase (ColGalT) and glucosyltransferase activities have been 22 
characterized using partially purified proteins (24, 31, 32), which appeared to be 23 
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instable. Recently, the lysyl hydroxylase-3 LH3 enzyme has been shown to catalyze a 1 
modest galactosyl- and glucosyltransferase activity, suggesting that this enzyme is a 2 
combined hydroxylase and glycosyltransferase (12). 3 
Prolyl and lysyl hydroxylation contribute to the stability of the collagen triple helix 4 
whereas hydroxylysine is essential for the cross-linking of collagen molecules, thus 5 
ensuring the strength of collagen fibrils (28). By contrast, the biological significance of 6 
collagen glycosylation is still unclear. The collagen domain of adiponectin and 7 
mannose-binding lectin also carry glycosylated hydroxylysine residues, which 8 
appear important for the oligomerization and proper secretion of these proteins (6, 9 
29). 10 
The importance of collagen post-translational modifications is reflected by the 11 
diseases caused by defective collagen modifying enzymes. Mutations of the LH1 12 
lysyl hydroxylase-1 gene lead to the connective tissue disorder Ehlers-Danlos 13 
syndrome type-VI (14) and mutations in the LH2 lysyl hydroxylase-2 gene lead to the 14 
Bruck syndrome (44). The deficiency of the prolyl-3-hydroxylase-1 gene causes a 15 
severe form of osteogenesis imperfecta (5). The availability of the collagen 16 
glycosyltransferase genes will enable the comprehensive investigation of this post-17 
translational modification in cellular and animal models and possibly in human 18 
diseases. 19 
20 
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Materials and Methods 1 
Affinity chromatography. Collagen glycosyltransferases were enriched by affinity 2 
chromatography as described by Myllyla et al. (1, 22, 24). Briefly, 10-day-old chicken 3 
embryos were homogenized in 225 mM mannitol, 75 mM sucrose, 50 μM DTT and 4 
50 mM Tris-HCl, pH 7.4 at 4 °C and centrifuged at 15,000 x g for 40 min. 5 
Supernatants were filtered and proteins precipitated in 60 % (NH4)2SO4. The pellets 6 
obtained after 20 min centrifugation at 15,000 x g were dissolved in 0.2 M NaCl, 7 
50 μM DTT, 1 % glycerol, 20 mM Tris-HCl, pH 7.4 and dialyzed overnight against 8 
2.5 l of enzyme buffer (0.15 M NaCl, 10 mM MnCl2, 50 M DTT, 1 % glycerol, 50 mM 9 
Tris-HCl, pH 7.4). The chicken protein extracts were loaded on a column of agarose-10 
bound bovine achilles collagen type-I fragments as described previously (32). The 11 
column was washed with 5 volumes of enzyme buffer containing 500 μM UDP fol-12 
lowed by elution with 0.1 % acetic acid. Collected fractions were immediately 13 
neutralized with 1 M Tris pH 8.0. 14 
 15 
MS peptide analysis. The eluted fractions from the affinity chromatography were 16 
desalted and concentrated with Amicon Ultra 10 cartridges (Millipore). Portions of 17 
2 μg protein were reduced in 0.6 M Tris pH 8.5, 50 mM DTT for 5 min at 80 °C and 18 
alkylated for 40 min at RT in the dark by the addition of iodoacetamide (Sigma-19 
Aldrich, final concentration 200 mM) and desalted by adding 9 volumes of ice cold 20 
methanol for 18 h on ice. Alkylated proteins were digested for 18 h at 37 °C with 21 
0.01 μg trypsin (Roche). ZipTip (Millipore) purified peptides were then analyzed by 22 
liquid chromatography-MS. The desalted peptide digest was adjusted to 0.2 % formic 23 
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acid, 3 % ACN and directly injected onto a custom packed 80 mm x 0.075 mm 1 
ProntoSil-Pur C18- AQ, 3 μm, 200 Å, column (Bischoff GmbH, Leonberg, Germany), 2 
connected to a LTQ-ICR-FT mass spectrometer (Thermo Scientific, Bremen, 3 
Germany). The peptides were eluted with a binary gradient of solvents A (3 % ACN, 4 
0.2 % formic acid) and B (80 % ACN, 0.2 % formic acid) using an Eksigent-Nano-5 
HPLC system (Eksigent technologies, Dublin, USA). The column was flushed for 6 
16 min at a flow rate of 500 nl/min with 100 % buffer A. Buffer B was increased to 7 
3 % over 5 min, to 60 % over 50 min, to 100 % over 3 min and held at 100 % for 7 min. 8 
During gradient elution, the flow rate was maintained at 200 nl/min. The mass 9 
spectral data were acquired in the mass range of 300-2000 m/z. Data dependent 10 
MS/MS spectra were recorded of up to four of the most intense ions with higher 11 
charge state than 1+ using collision-induced dissociation (CID). Target ions already 12 
selected for MS/MS were dynamically excluded for 60 s. Peptide signals exceeding 13 
500 counts were subjected to CID with normalized collision energy of 32 %. MS and 14 
MS/MS data were searched using Mascot Server 2.1 (Matrix Science, London, UK) as 15 
the search engine. Modifications used include carbamidomethylation (Cys, fixed) 16 
and oxidation (Met, variable). The monoisotopic masses of +2, and +3 charged 17 
peptides were searched with a peptide tolerance of 2 ppm and MS/MS tolerance of 18 
0.8 Da. MS/MS spectra were searched against the UniRef100 20051018 database 19 
(2764545 sequences; 1015909965 residues) downloaded from the European 20 
Bioinformatics Institute (http://www.ebi.ac.uk/uniprot/database/download.html) 21 
and the Gallus gallus predicted proteins database from the Ensemble Genome 22 
Browser 23 
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ftp://ftp.ensembl.org/pub/current_chicken/data/fasta/pep/Gallus_gallus.WASH1 
UC1.jul.pep.abinitio.fa.gz,August 2005).  2 
 3 
Cloning and protein expression. The GLT25D2, LH3 and MBL cDNAs were 4 
purchased from the RZPD repository (Berlin, Germany). The GLT25D1 and cerebral 5 
endothelial cell adhesion molecule-1 (CEECAM1) cDNAs were cloned by RT-PCR from 6 
human fibroblast total RNA using the primers 5'-7 
ATCTGAATTCCCTTTAAGGCGCGGCCAGAGTC-3', 5'-8 
ATGTCTAGATGGAGCCTGGGCCACCGATG-3' for GLT25D1, and 5'-9 
CGTAGAATTCGAGAGCTCCGGGGGCCGCT3', 5'-10 
GACTATCTAGAGTAGTGGCCTGCTCCTGGAC-3' (Microsynth, Switzerland) for 11 
CEECAM1. The RT-PCR products were subcloned as EcoRI-XbaI fragments into the 12 
pFastBacI baculovirus transfer vector (Invitrogen). The MBL cDNA was subcloned 13 
into the EcoRI site of the pFmel-protA vector (48) to yield a protein-A fusion protein. 14 
The corresponding 732 bp MBL fragment was amplified with the primers 5’-15 
ATCGAATTCATGGTGGCAGCGTCTTACTC-3’ and 5’-16 
ATCGAATTCAGGAGGGCCTGAGTGATATG-3’. Recombinant baculoviruses were 17 
produced in S. frugiperda Sf9 cells as described previously (13). Protein-A tagged 18 
MBL was co-expressed together with LH3, purified from the supernatant of infected 19 
Sf9 cells by IgG Sepharose chromatography (48) and subsequently used as acceptor 20 
for the enzymatic activity assay. The expression of the recombinantly expressed 21 
enzymes was analyzed on a 10 % SDS-PAGE gel. Prior to electrophoresis, proteins 22 
were enriched by concanavalin-A Sepharose (GE Healthcare) chromatography. 23 
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Protein bands were excised from the SDS-PAGE gel, digested in gel with trypsin 1 
according to Shevchenko et al (34) and identified by MS peptide analysis. 2 
 3 
Preparation of ColGalT acceptors. Bovine Achilles collagen type-I, bovine nasal 4 
septum collagen type-II, human placenta collagen type-III, -IV and -V (Sigma) were 5 
deglycosylated by trifluoromethane sulfonic acid (TFMS)-mediated cleavage (7, 38). 6 
Acceptor proteins (50 μg) were lyophilized followed by an incubation in a dry 7 
ice/ethanol bath for 20 min. Proteins were dissolved in 50 μl TFMS/toluene (16.6:1, 8 
v:v) (Sigma-Aldrich). Reactions were subsequently incubated at -20 °C for 24 h, then 9 
neutralized with 150 μl pyridine/H2O (2:1, v:v) in the dry ice/ethanol bath followed 10 
by 15 min incubation on ice. The sample was mixed with 400 μl 50 mM ammonium 11 
acetate and dialyzed overnight against 2.5 l of 50 mM ammonium acetate. 12 
 13 
Collagen glycosyltransferase assays. Baculovirus infected Sf9 cells were lyzed in 1 % 14 
Triton-X100/TBS pH 7.4 for 10 min on ice and postnuclear supernatant was used as 15 
enzyme source. Collagen was heat denatured for 10 min at 60 °C in sodium acetate 16 
pH 6.8 and rapidly cooled down to 0 °C before use. Assays were performed with 17 
10 μl of Sf9 postnuclear supernatant in a final volume of 100 μl containing 0.5 mg/ml 18 
collagen acceptors, 60 μM UDP-Gal or UDP-Glc, 50,000 cpm UDP-[14C]Gal or UDP-19 
[14C]Glc (GE Healthcare), 10 mM MnCl2, 20 mM NaCl, 50 mM MOPS pH 7.4, 1 mM 20 
DTT. Reactions were incubated for 3 h at 37 °C and stopped by the addition of 500 µl 21 
of ice cold 5 % TCA / 5 % phosphotungstic acid. Enzymatic activity assays for Km 22 
  9 
analysis were performed as described above but with varying amounts of either 1 
collagen type-I or UDP-Gal as substrates. 2 
  3 
Amino acid analysis. The reaction products of the collagen galactosyltransferase 4 
assays were hydrolyzed in 4 M NaOH for 72 h at 105 °C and the resulting single 5 
amino acids were derivatized with Fmoc according to Bank et al. (2). RP-HPLC 6 
(LaChrom Hitachi, Merck) of single amino acids was performed on a ODS Hypersil 7 
column, 150 x 3 mm, 3 μm particle size (Thermo Electron Corporation) at 40 °C. The 8 
galactosylated Hyl (GHyl) and galactosyl-glucosylated Hyl (GGHyl) standards were 9 
kindly provided by Ruggero Tenni (University of Pavia) (42). Amino acids were 10 
separated at a flow rate of 0.2 ml/min using a gradient elution (Table S1) with the 11 
solvents 0.5 M citric acid, 5 mM (CH3)4NCl, pH 2.85 (A); 80 % of 20 mM sodium 12 
acetate trihydrate, 5 mM (CH3)4NCl, pH 4.5, 20 % of methanol (B); 100 % of ACN (C). 13 
Radiolabeled [3H]Val and [14C]Tyr (Moravek Biochemicals and Radiochemicals, 14 
USA) were used as internal standard. Radioactivity was counted in a β-counter (Tri-15 
Carb 2900TR, Packard). For β-galactosidase digestion of GHyl, hydrolyzed amino 16 
acids were loaded on AG 50W-X8(H+) (Bio-Rad), washed with 0.8 % acetic acid and 17 
eluted with 5 % ammonia. After removal of ammonia by lyophilization, the samples 18 
were digested with 10 mU of bovine testis β-galactosidase (QA-Bio, San Mateo, CA) 19 
in 100 mM sodium citrate, pH 4.3 for 16 h at 37 °C. Liberated Gal was separated from 20 
GHyl by passage through AG 50W-X8(H+), whereas G-Hyl was released by elution 21 
with 5 % ammonia. 22 
 23 
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RNA interference. Lentivirus particles expressing the short hairpin RNA constructs 1 
TRCN0000034884, TRCN0000034885, TRCN0000034887 and TRCN0000034888 2 
targeting human GLT25D1 (MISSION shRNA NM_024656, Sigma) were produced in 3 
HEK293T cells as described previously (10). Aliquots of 500 µl of lentivirus-4 
producing HEK293T cell supernatants were added to 60’000 HeLa cells for 24 h. Cells 5 
expressing the short hairpin RNA constructs were selected by 2.5 µg/ml of 6 
puromycin for 10 days. Silencing of the GLT25D1 gene was monitored by 7 
quantitative RT-PCR (SYBR Green JumpStart Taq ReadyMix , Sigma) using the 8 
primers 5'-ATTGCGCGCCCACAGCAC-3' and 5'-GGTGGGAGCCGAGATGAAGC-9 
3'. The expression of the GLT25D2 and of the GAPDH genes in HeLa cells was 10 
determined with the primers 5'-GATAACATTGACCAGGCTCAG-3', 5'-11 
CCCAAAAGGATTGGCTCCAAC-3', 5'-ATGCTGGCGCTGAGTACGTCGTG-3' and 12 
5'-GTGATGGCATGGACTGTGGTCAT-3', respectively. 13 
 14 
Northern blotting. The GLT25D1, GLT25D2 and CEECAM1 cDNA probes were 15 
synthesized by PCR using the primers 5'-GATGAGGCCGAGAGCTTCATGC-3' and 16 
5'-GCATGAAGCTCTCGGCCTCATC-3', 5'-AAGCAGGCATCCAGATGTACC-3' and 17 
5'-TCCAGCTGAGCCTGGTCAATG-3', 5'-GTGGATGGCTGGATGCTCAAC-3' and 18 
5'-GACTATCTAGAGTAGTGGCCTGCTCCTGGAC-3', respectively. The resulting 19 
676 bp-long GLT25D1, 559 bp-long GLT25D2 and 785 bp-long CEECAM1 probes 20 
were labeled with α[32P]dCTP (Hartman Analytic, Germany) by random priming 21 
(Stratagene). Multiple human tissue RNA blots (MTE array 3, BD Bioscience and First 22 
Choice Northern Human Blot 1, Ambion) were prehybridized with QuikHyb® 23 
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hybridization solution (Stratagene) containing 100 μg/ml ultra pure herring sperm 1 
DNA (Invitrogen) for 1 h at 65 °C, then hybridized with 5 x 105 cpm of each labeled 2 
probe overnight at 65 °C. The arrays were washed in 0.1 x SSC, 0.1 % SDS up to 60 °C 3 
and exposed on BioMax XAR film (Kodak) for 24 h at -80 °C.  4 
5 
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Results 1 
ColGalT identification. Most glycosylation pathways have been characterized at the 2 
molecular level over the past decades. However, the genes encoding the 3 
glycosyltransferases involved in the glycosylation of Hyl in collagen have remained 4 
unknown up to now. Here, we have applied a cloning strategy based on the 5 
enrichment of proteins by affinity chromatography, peptide sequencing and 6 
heterologous expression of isolated candidate proteins. The enrichment procedure 7 
followed the method of Myllyla et al. (32) using immobilized denatured collagen 8 
type-I to capture the ColGalT. Homogenates of 10-day-old chicken embryos were 9 
used as source of ColGalT enzyme as applied previously (1, 24). To identify potential 10 
ColGalT enzymes among the proteins enriched by the affinity chromatography, we 11 
selected proteins sharing sequence homology with known glycosyltransferases. We 12 
also narrowed down on proteins containing ER-localization motifs considering the 13 
cellular localization of collagen glycosylation and on proteins containing N-14 
glycosylation sites since it was shown that the ColGalT activity could by enriched by 15 
concanavalin-A lectin chromatography (30). 16 
One of the candidate proteins identified by tandem-MS peptide sequencing was the 17 
putative glycosyltransferase GLT25D2 (Fig. 1A, Fig. S1). GLT25D2 is a type-II 18 
transmembrane protein of 626 amino acids including four N-glycosylation sites and 19 
the ER-retention signal RDEL at the C-terminus (Fig. 1B). No enzymatic activity was 20 
attributed to GLT25D2 but database annotations pointed to sequence homology with 21 
bacterial enzymes involved in LPS biosynthesis. Similar proteins to the chicken 22 
GLT25D2 could be deduced from all metazoan genomes. In the human genome, 23 
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GLT25D2 was found to be strongly similar to two proteins, namely GLT25D1 and 1 
CEECAM1. The three proteins contained N-glycosylation sites and the ER retrieval 2 
signal RDEL at the C-terminus and shared above 50 % sequence identity (Fig. 2). 3 
ColGalT activity. The putative ColGalT activity of GLT25D1, GLT25D2 and 4 
CEECAM1 was assayed by expressing the three proteins as recombinant baculovirus 5 
in Sf9 insect cells. Five types of collagen were tested as possible acceptor substrates. 6 
Because native collagen is readily glycosylated to varying extents, we also included 7 
deglycosylated collagen preparations in the assays. GLT25D1 and GLT25D2 showed 8 
a strong ColGalT activity on all deglycosylated collagen acceptors tested, whereas 9 
CEECAM1 did not show any activity (Table 1). As expected, the ColGalT activity of 10 
GLT25D1 and GLT25D2 was lower when using native collagen acceptors. 11 
Noteworthy, collagen type-IV and collagen type-V in the native form were hardly 12 
galactosylated by GLT25D1 and GLT25D2, suggesting that most Hyl residues were 13 
already glycosylated. In addition to true collagens, GLT25D1 and GLT25D2, but not 14 
CEECAM1, were able to transfer Gal to the serum protein MBL (Fig. 3), which 15 
contains four Hyl sites in its collagen domain, showing that ColGalT activity was not 16 
limited to large collagen acceptors. The nucleotide-sugars UDP-GlcNAc and UDP-17 
GalNAc were also tested as possible donor substrates but no GlcNAc- or GalNAc-18 
transfer to collagen could be detected (data not shown). 19 
We also tested the ColGalT activity of the human LH3 enzyme, which had been 20 
reported to catalyze three reactions on collagen, namely the hydroxylation of Lys, 21 
plus the β(1-O)galactosylation and α(1-2)glucosylation of Hyl (12, 47). Surprisingly, 22 
we could not detect any significant ColGalT activity for LH3 under our assay 23 
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conditions using bovine Achilles collagen type-I as acceptor (Fig. 4A). However, as 1 
described previously (12, 47), we did measure a low collagen glucosyltransferase 2 
activity for LH3, whereas GLT25D1, GLT25D2 and CEECAM1 failed to show any 3 
significant collagen glucosyltransferase activity (Fig. 4B). Although no collagen 4 
glycosyltransferase activity could be attributed to CEECAM1, we did confirm that 5 
the recombinant protein was expressed in Sf9 cells like GLT25D1, GLT25D2 and LH3, 6 
as shown by SDS-PAGE (Fig. 4C). To confirm the identity of the GLT25D1, GLT25D2, 7 
CEECAM1 and LH3 proteins, the corresponding bands were excised from the gel, 8 
digested with trypsin and submitted to tandem-MS peptide sequencing (data not 9 
shown). However, even if shown to be expressed, it is still possible that the levels of 10 
CEECAM1 could be too low to detect activity.     11 
Km values. The apparent Km of GLT25D1 and GLT25D2 was determined for the 12 
bovine collagen type-I acceptor and for UDP-Gal as donor substrate, since these 13 
values had been reported previously for the semi-purified ColGalT activity (23). The 14 
Km of GLT25D1 and GLT25D2 for the collagen type-I acceptor was 13.6 g/l and 15 
9.8 g/l, respectively (Fig. 5A, C), whereas Myllyla et al. reported a Km of 150 g/l for 16 
the partially purified chicken ColGalT enzyme. The Km values for UDP-Gal were 17 
18.77 μM for GLT25D1 and 33.53 μM for GLT25D2 (Fig. 5B, D). These values are 18 
comparable to those reported by Myllyla et al, who determined a Km for UDP-Gal of 19 
30 μM for the partially purified chicken ColGalT (23).  20 
ColGalT reaction products. The products of the GLT25D1 and GLT25D2 mediated 21 
ColGalT reactions were further analyzed to confirm the transfer of β-linked Gal to 22 
Hyl residues on collagen. The reaction products were hydrolyzed in 4 M NaOH to 23 
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yield single amino acids. After derivatization with Fmoc and separation by reverse 1 
phase HPLC, the amino acid profiles obtained from collagen type-I, collagen type-II 2 
and from the GLT25D1-, GLT25D2-reacted collagen acceptors were compared to a 3 
profile of authentic amino acid standards. The amount of GHyl and GGHyl was 4 
higher in collagen type-II than in collagen type-I as measured by the ratio GHyl/Hyl 5 
and GGHyl/Hyl, respectively (Fig. 6). This finding was in agreement with the values 6 
reported in the literature (16). The analysis of additional types of collagen, such as 7 
collagen type-IV and sponge collagen confirmed the variable extent of Hyl 8 
glycosylation across collagens (data not shown). The amino acid profiles obtained 9 
after GLT25D1 and GLT25D2 reactions in the presence of UDP-[14C]Gal were further 10 
analyzed by β-counting (Fig. 6, lower panel). The [14C]Gal signal co-migrated with 11 
the GHyl standard, indicating that GLT25D1 and GLT25D2 indeed represent true 12 
ColGalT enzymes. To demonstrate the β-linkage between Gal and Hyl, the GLT25D1 13 
and GLT25D2 reaction products were digested with β-galactosidase. [14C]Gal-Hyl 14 
was prepared by alkaline hydrolysis of GLT25D1 and GLT25D2 reaction products 15 
and samples of 25,000 cpm were incubated overnight with bovine testes β-16 
galactosidase. More than 80% of the radioactivity was recovered as free [14C]Gal after 17 
β-galactosidase digestion, which confirmed the β-configuration of the linkage 18 
catalyzed by the GLT25D1 and GLT25D2 enzymes (Table 2). 19 
ColGalT gene silencing. To correlate the expression of the GLT25D1 enzyme with 20 
the endogenous ColGalT activity in human cells, we have silenced the GLT25D1 gene 21 
in HeLa cells by RNA interference. HeLa cells only expressed the GLT25D1 gene, 22 
whereas GLT25D2 expression remained undetected by RT-PCR (Fig. 7A). The 23 
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GLT25D1 gene was silenced by introducing short hairpin RNA constructs into HeLa 1 
cells. The GLT25D1 expression was reduced to 31%, 67% and 39% of normal mRNA 2 
levels when expressing combinations of short hairpin RNA probes (Fig. 7B). The 3 
endogenous ColGalT activity of HeLa cells was measured and found to reach 5.7 4 
pmol.min-1mg prot-1 in wildtype cells whereas it was decreased to 2.0, 3.7 and 2.1 5 
pmol.min-1mg prot-1 in GLT25D1-knockdowned cells. When normalizing the ColGalT 6 
activity of wildtype HeLa cells to 100%, this activity was decreased to 35%, 65% and 7 
37% in GLT25D1-knockdowned cells (Fig. 7C). The direct comparison between the 8 
level of GLT25D1 expression and ColGalT activity in HeLa cells showed a strong 9 
correlation (Fig. 7D), thereby establishing a link between the GLT25D1 enzyme and 10 
the ColGalT activity in vivo.  11 
ColGalT gene expression. The expression of GLT25D1, GLT25D2 and CEECAM1 in 12 
human tissues was analyzed by Northern blotting on 10 human tissues. A single 13 
GLT25D1 transcript of 3.7 kb was detected in all tissues, whereas mRNA levels were 14 
highest in placenta, heart, lung and spleen (Fig. 8A). By contrast, the GLT25D2 gene 15 
yielded a 5.1 kb mRNA that was detected only in brain and skeletal muscle at lower 16 
levels (Fig. 8A). A 2.3 kb CEECAM1 transcript was detected in most tissues 17 
investigated, while a second transcript of 5.9 kb was also detected in brain (Fig. 8A). 18 
The survey of GLT25D1, GLT25D2 and CEECAM1 gene expression was extended to 19 
75 human tissues and cell types using a Northern dot blotting array. The broad 20 
expression of the GLT25D1 gene was confirmed in fetal and adult human tissues (Fig. 21 
8B, Fig. S2). Similarly, the narrow range of GLT25D2 gene expression was also 22 
evident throughout the RNA array (Fig. 8B, Fig. S2). The CEECAM1 gene, which 23 
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could not be related to a ColGalT activity, showed a widespread expression across 1 
tissues. Notably, CEECAM1 was highly expressed in secretory tissues like salivary 2 
glands, pancreas and placenta and in the nervous system (Fig. 8B, Fig. S2). 3 
Additionally, the GLT25D1 and CEECAM1 genes, but not GLT25D2, were also 4 
expressed in various carcinoma cell lines (Fig. S2). This survey of ColGalT gene 5 
expression suggested that GLT25D1 represents the main source of ColGalT activity 6 
in human tissues, while GLT25D2 appears to be specialized to few cell types and 7 
possibly to few collagen acceptors. 8 
9 
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Discussion 1 
The identification of the GLT25D1 and GLT25D2 ColGalT enzymes and of the 2 
similar, yet inactive, relative CEECAM1 protein raises the question of a possible 3 
restricted specificity towards collagen acceptor substrates. Previous work has shown 4 
that ColGalTs recognizes collagen peptides of at least 500-600 Da and that Hyl alone 5 
is not a suitable acceptor (23, 31). The different activity levels of recombinant 6 
GLT25D1 and GLT25D2 enzymes towards the various types of collagen tested 7 
support the idea of a differential substrate recognition. The nature of the substrate 8 
recognition may be complex and may include glycosylated residues as part of the 9 
motifs recognized. In fact, GLT25D2 was more active towards native collagen type-I 10 
and type-II than towards the deglycosylated forms of these proteins (Table 1), which 11 
indicates that glycan chains somehow affected the recognition of the acceptor 12 
substrate by GLT25D2. Along the same line, the apparent inactivity of CEECAM1 13 
may be due to stringent structural requirements regarding the recognition of 14 
collagen peptides. A similarly complex mechanism of substrate recognition has been 15 
described for core glycosyltransferases acting on mucin proteins. Some members of 16 
the polypeptide N-acetylgalactosaminyltransferase family recognize peptide 17 
acceptors including serine or threonine residues near residues that were previously 18 
glycosylated by other N-acetylgalactosaminyltransferases (3). ColGalT assays with 19 
synthetic peptides including Hyl and GHyl at various positions will certainly answer 20 
the question of the acceptor substrate recognition. 21 
Alternatively, it is possible that CEECAM1 represents a ColGalT acting on a limited 22 
set of substrates. The screening of additional proteins including collagen domains 23 
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like adiponectin, the acetylcholine esterase complex COLQ, and the complement 1 
protein C1q might confirm this eventuality. Finally, CEECAM1 may have lost any 2 
enzymatic activity over the course of evolution. In fact, CEECAM1 was first 3 
described as an adhesion protein (41), which might function as a carbohydrate-4 
binding protein at the cell surface. However, the presence of the C-terminal RDEL 5 
motif would suggest that CEECAM1 is maintained in the ER. 6 
The lysyl hydroxylase LH3 protein has been previously reported to possess three 7 
enzymatic activities, namely a lysyl hydroxylase, a ColGalT and a collagen 8 
glucosyltransferase activity (47). The glycosyltransferase activities attributed to LH3 9 
were very low, casting doubt on their biological significance (27). The ColGalT 10 
activity of LH3 reported previously reached approximately twice the levels of 11 
endogenous ColGalT activity measured in Sf9 cells (47). It is possible that we could 12 
not distinguish the ColGalT activity of LH3 from the background activity levels in 13 
our assays. By comparison, the strong ColGalT activity described here for GLT25D1 14 
and GLT25D2 implies that these proteins indeed represent true ColGalT enzymes. 15 
The dual glycosyltransferase activity of LH3 certainly requires closer attention as it is 16 
expected that the catalysis of both β(1-O) and α(1-2) linkages would require distinct 17 
domains responsible for the retaining α(1-2) and inverting β(1-O) glycosyltransferase 18 
activities (26). 19 
The identification of the GLT25D1 and GLT25D2 genes as encoding two ColGalT 20 
enzymes opens new ways to investigate the biological significance of collagen 21 
glycosylation. Genes similar to the human GLT25D1 and GLT25D2 genes can be 22 
found in all metazoan genomes sequenced to date. For example, the C. elegans gene 23 
  20 
D2045.9 represents the probable ortholog to the human GLT25D1 and GLT25D2 1 
genes. Knockdown of the D2045.9 gene by RNA interference yields multiple 2 
abnormalities like deformed mating organs, slow growth and uncoordinated 3 
locomotion (15, 36). By comparison, the loss of the lysyl hydroxylase gene let-268 4 
leads to a lethal phenotype associated to a defect in collagen type-IV secretion (21, 5 
25). The conservation of collagen glycosylation throughout animals and the essential 6 
role of collagen glycosylation in worms emphasize the importance of this 7 
modification. In humans, the GLT25D1 and GLT25D2 genes are found on human 8 
chromosome 19p13 and chromosome 1q25, respectively. The involvement of 9 
ColGalTs in the pathogenesis of connective tissue disorders linked to chromosomes 10 
19p13 and 1q25, such as psoriasis (19) and epidermolysis bullosa (8, 18) can now be 11 
straightforwardly documented. 12 
13 
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Table 1. ColGalT activity measured in Sf9 cell lysates. Values represent the 
average ± S.D. of 4 assays. 
Collagen TFMS a Sf9 b GLT25D1 GLT25D2 CEECAM1 
  (pmol.min-1.mg prot-1) 
no acceptor  1.5 ± 0.6 1.9 ± 0.7 0.9 ± 0.4 0.5 ± 0.1 
Type I - 10.5 ± 1.8 43.7 ± 12.0 57.2 ± 8.5 8.7 ± 2.0 
 + 5.0 ± 3.0 61.4 ± 18.2 18.0 ± 5.4 2.7 ± 1.9 
Type II - 6.5 ± 0.8 36.6 ± 3.7 35.1 ± 3.8 3.3 ± 1.3 
 + 3.4 ± 0.8 67.0 ± 16.5 22.1 ± 8.8 2.8 ± 0.8 
Type III - 2.9 ± 0.9 31.7 ± 5.8 25.2 ± 6.8 1.8 ± 0.8 
 + 11.0 ± 3.6 244.7 ± 25.7 102.1 ± 17.6 6.5 ± 1.7 
Type IV - 1.7 ± 1.4 3.6 ± 2.2 3.6 ± 0.9 1.9 ± 0.7 
 + 12.9 ± 4.6 433.2 ± 49.6 164.2 ± 43.3 8.4 ± 2.4 
Type V - 2.3 ± 0.7 2.7 ± 0.3 2.3 ± 0.4 0.7 ± 0.1 
+ 2.7 ± 1.6 18.6 ± 3.6 4.7 ± 1.5 2.0 ± 1.1 
 5 
a TFMS-mediated deglycosylation 6 
b Sf9 cells infected with an empty baculovirus 7 
 8 
9 
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Table 2. β-Galactosidase digestion of GLT25D1 and GLT25D2 reaction products.  
Values represent the average of 2 independent experiments. 
  Input (cpm)   Products (cpm) 
Enzyme β-Galactosidase G-Hyl G-Hyl Gal 
GLT25D1 +  25,000  3,780  19,376 
GLT25D1 -  25,000  20,996  1,073 
GLT25D2 +  25,000  3,528  20,362 
GLT25D2 -  25,000  20,313  1,029 
  31 
Figure Legends 1 
Figure 1
 7 
: ColGalT identification by mass spectrometry. Proteins isolated by affinity 2 
chromatography were analyzed by LC-MS. (A) Peptide fragment spectra of two 3 
peptides identifying GLT25D2, (B) protein sequence of the Gallus gallus GLT25D2. 4 
The two identifying peptides are shaded in grey, the four potential N-glycosylation 5 
sites are underlined and the ER retrieval signal is shown in bold. 6 
Figure 2
 14 
: Protein alignment. The three putative human ColGalT enzymes share a 8 
high degree of sequence identity (63 % between GLT25D1 and GLT25D2, 50% 9 
between GLT25D2 and CEECAM1, 55 % between GLT25D1 and CEECAM1). The 10 
proteins include the C-terminal RDEL ER retrieval motif. Black squares represent 11 
amino acids identical or similar in all 3 proteins; grey squares represent amino acids 12 
identical or similar in 2 of the proteins. 13 
Figure 3
 19 
: ColGalT activity towards MBL. MBL was produced in Sf9 cells co-infected 15 
with a baculovirus expressing LH3. ColGalT activity assay was performed as 16 
described in the Experimental procedures section. Bars indicate the means of four 17 
assays. Error bars indicate the SD. 18 
Figure 4: Time course of baculovirus mediated protein expression in Sf9 cells. (A) 20 
ColGalT activity and (B) collagen glucosyltransferase activity measured in cells 21 
expressing GLT25D1 (▲), GLT25D2 (), CEECAM1 (), LH3 (). Bovine Achilles 22 
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collagen type-I was used as acceptor substrate. The activity measured in Sf9 infected 1 
with an empty baculovirus is shown in both panels with filled squares ().Values 2 
indicate the means of four assays. Error bars indicate the SD. (C) SDS-PAGE of 3 
recombinantly expressed proteins. Arrows indicate the recombinant protein bands, 4 
as confirmed by LC-MS mediated protein sequencing. 5 
 6 
Figure 5
 14 
: Determination of the apparent Km of GLT25D1 and GLT25D2. (A) 7 
Lineweaver Burk blot for GLT25D1 on collagen, with the calculated Michaelis-8 
Menten constant of 13.6 g/l. (C) Lineweaver Burk blot for GLT25D2 on collagen 9 
type-I with the calculated Michaelis-Menten constant of 9.8 g/l. (B) Lineweaver Burk 10 
blot for GLT25D1 on UDP-Gal with the calculated Michaelis-Menten constant of 11 
18.77 μM . (D) Lineweaver Burk blot for GLT25D2 on UDP-Gal with the calculated 12 
Michaelis-Menten constant of 33.53 μM. 13 
Figure 6
 22 
: Product identification by RP-HPLC. The first panel represents an amino 15 
acid standard containing the standards for G-Hyl and GG-Hyl. The second and the 16 
third panels show the amino acid profiles of bovine collagen type-I and type-II 17 
hydrolysates, respectively. The lower two panels show the radioactive trace obtained 18 
after reaction of collagen type-I with GLT25D1 and GLT25D2. [3H]Val and [14C]Tyr 19 
were used as internal amino acid standards. Amino acids are marked in single-letter 20 
code. Hyp, hydroxyproline. 21 
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Figure 7
 7 
: Silencing of the GLT25D1 gene. (A) RT-PCR detection of GLT25D1 and 1 
GLT25D2 expression in HeLa cells. (B) mRNA GLT25D1 levels in wildtype HeLa cells 2 
(black bar) and in GLT25D1-silenced HeLa cells (KD#1-3, white bars). (C) Relative 3 
ColGalT activity in wildtype HeLa cells (black bar) and in GLT25D1-silenced HeLa 4 
cells (white bars). (D) Comparison between GLT25D1 mRNA levels and ColGalT 5 
activity in wildtype HeLa cells (set to 100%) and in GLT25D1-silenced HeLa cells. 6 
Figure 8: Tissue Northern blotting. (A) The mRNA expression patterns of GLT25D1, 8 
GLT25D2 and CEECAM1 were analyzed in 10 human tissues and (B) in 36 human 9 
tissues and cell lines, whereas a representative collection of additional tissues and 10 
cell types is shown in  Fig. S2. PBL, peripheral blood leukocytes. 11 
XGSIADHWSEKKSMCISNGRKLILIASRTVSILTIVTHRA    1
SYPGASGWLPLEQMTWHQLPSAVQGCSAILQYTAVGEGPR   41
ILQPSEHGQEGKGSLLQLQQPPAFALFCTLETLIMKYLPL   81
FANGGGWVATDHNADNTTAILREWLKNVQNLYHDVEWRPM  121
EDPQSYPEEMGPKHWPSSRFTHVMKLRQAALRAAREKWSD  161
YVLFLDTDNLLTNPETLNLLIAENKTLVAPMLESRFLYSN  201
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GLT25D1 : LVAVKSLYHSVEWRPAEEPRSYPDEEGPKHWSDSRYEHVMKLRQAALKSARDMWADYILFVDADNLILNPDTLSLLIAENKTVVAPMLDSRAAYSNFWCGMTSQG : 209 
GLT25D2 : LKNVQRLYHYVEWRPMDEPESYPDEIGPKHWPTSRFAHVMKLRQAALRTAREKWSDYILFIDVDNFLTNPQTLNLLIAENKTIVAPMLESRGLYSNFWCGITPKG : 210 
CEECAM1 : LAAVGDDYAAVVWRPEGEPRFYPDEEGPKHWTKERHQFLMELKQEALTFARNWGADYILFADTDNILTNNQTLRLLMGQGLPVVAPMLDSQTYYSNFWCGITPQG : 188 
                                                                                                                          
                 220                 240                 260                 280                 300                      
GLT25D1 : YYKRTPAYIPIRKRDRRGCFAVPMVHSTFLIDLRKAASRNLAFYPPHPDYTWSFDDIIVFAFSCKQAEVQMYVCNKEEYGFLPVPLRAHSTLQDEAESFMHVQLE : 314 
GLT25D2 : FYKRTPDYVQIREWKRTGCFPVPMVHSTFLIDLRKEASDKLTFYPPHQDYTWTFDDIIVFAFSSRQAGIQMYLCNREHYGYLPIPLKPHQTLQEDIENLIHVQIE : 315 
CEECAM1 : YYRRTAEYFPTKNRQRRGCFRVPMVHSTFLASLRAEGADQLAFYPPHPNYTWPFDDIIVFAYACQAAGVSVHVCNEHRYGYMNVPVKSHQGLEDERVNFIHLILE : 293 
                                                                                                                          
            320                 340                 360                 380                 400                 420       
GLT25D1 : VMVKHPPAEPSRFISAPTKTPDKMGFDEVFMINLRRRQDRRERMLRALQAQEIECRLVEAVDGKAMNTSQVEALGIQMLPGYRDPYHGRPLTKGELGCFLSHYNI : 419 
GLT25D2 : AMIDRPPMEPSQYVSVVPKYPDKMGFDEIFMINLKRRKDRRDRMLRTLYEQEIEVKIVEAVDGKALNTSQLKALNIEMLPGYRDPYSSRPLTRGEIGCFLSHYSV : 420 
CEECAM1 : ALVDGPRMQASAHVTRPSKRPSKIGFDEVFVISLARRPDRRERMLASLWEMEISGRVVDAVDGWMLNSSAIRNLGVDLLPGYQDPYSGRTLTKGEVGCFLSHYSI : 398 
                                                                                                                          
                           440                 460                 480                 500                 520            
GLT25D1 : WKEVVDRGLQKSLVFEDDLRFEIFFKRRLMNLMRDVEREGLDWDLIYVGRKRMQVEHPEKAVPRVRNLVEADYSYWTLAYVISLQGARKLLAAEPLSKMLPVDEF : 524 
GLT25D2 : WKEVIDRELEKTLVIEDDVRFEHQFKKKLMKLMDNIDQAQLDWELIYIGRKRMQVKEPEKAVPNVANLVEADYSYWTLGYVISLEGAQKLVGANPFGKMLPVDEF : 525 
CEECAM1 : WEEVVARGLARVLVFEDDVRFESNFRGRLERLMEDVEAEKLSWDLIYLGRKQVNPEK-ETAVEGLPGLVVAGYSYWTLAYALRLAGARKLLASQPLRRMLPVDEF : 502 
                                                                                                                          
                      540                 560                 580                 600                 620             
GLT25D1 : LPVMFDKHPVSEYKAHFSLRNLHAFSVEPLLIYPTHYTGDDGYVSDTETSVVWNNEHVKTDWDRAKSQKMREQQALSREAKNSDVLQSP--LDSA-ARDEL : 622 
GLT25D2 : LPVMYNKHPVAEYKEYYESRDLKAFSAEPLLIYPTHYTGQPGYLSDTETSTIWDNETVATDWDRTHAWKSRKQSRIYSNAKNTEALPPPTSLDTVPSRDEL : 626 
CEECAM1 : LPIMFDQHPNEQYKAHFWPRDLVAFSAQPLLAAPTHYAGDAEWLSDTETSSPWDDDSGR-LISWSGSQKTLRSPRLDLTGSSGHSLQPQ-------PRDEL : 595 
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